Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irene Karampela

Showing results (1-10 of 92) with videos related to

Pageof 10
Sort By:
Metabolism Open|December 26, 2022
Perspectives in vaccines, immune response, therapeutic interventions and COVID-19Irene Karampela
Metabolism Open|May 24, 2021
Serum bilirubin to fetuin-A ratio as a prognostic biomarker in critically ill patients with sepsisIrene Karampela, Maria Dalamaga
Saudi Medical Journal|January 9, 2019
Comment to: Are fetuin-A levels beneficial for estimating timing of sepsis occurrence?Irene Karampela, Maria Dalamaga
Archives of Medical Research|June 18, 2020
Could Respiratory Fluoroquinolones, Levofloxacin and Moxifloxacin, Prove to be Beneficial as an Adjunct Treatment in COVID-19?Irene Karampela, Maria Dalamaga
Journal of Critical Care|November 6, 2017
Fetuin-A to adiponectin ratio is a promising prognostic biomarker in septic critically ill patientsMaria Dalamaga, Irene Karampela
Medicina (Kaunas, Lithuania)|July 27, 2022
Future Perspectives in the Diagnosis and Treatment of Sepsis and Septic ShockIrene Karampela, Paraskevi C Fragkou
Metabolism Open|April 20, 2026
COVID-19 and metabolic health: Lessons from a global pandemicMaria Dalamaga, Irene Karampela, Junli Liu
Ophthalmology and Therapy|September 28, 2020
Does COVID-19 Involve the Retina?Michael Karampelas, Maria Dalamaga, Irene Karampela
Ophthalmology and Therapy|September 21, 2020
Does COVID-19 Involve the Retina?Michael Karampelas, Maria Dalamaga, Irene Karampela
Metabolism: Clinical and Experimental|June 5, 2020
Commentary: Phosphodiesterase 4 inhibitors as potential adjunct treatment targeting the cytokine storm in COVID-19Maria Dalamaga, Irene Karampela, Christos S Mantzoros
Pageof 10

Showing results (1-10 of 92) with videos related to

Sort By:
Pageof 10
Metabolism Open|December 26, 2022
Perspectives in vaccines, immune response, therapeutic interventions and COVID-19Irene Karampela
Metabolism Open|May 24, 2021
Serum bilirubin to fetuin-A ratio as a prognostic biomarker in critically ill patients with sepsisIrene Karampela, Maria Dalamaga
Saudi Medical Journal|January 9, 2019
Comment to: Are fetuin-A levels beneficial for estimating timing of sepsis occurrence?Irene Karampela, Maria Dalamaga
Archives of Medical Research|June 18, 2020
Could Respiratory Fluoroquinolones, Levofloxacin and Moxifloxacin, Prove to be Beneficial as an Adjunct Treatment in COVID-19?Irene Karampela, Maria Dalamaga
Journal of Critical Care|November 6, 2017
Fetuin-A to adiponectin ratio is a promising prognostic biomarker in septic critically ill patientsMaria Dalamaga, Irene Karampela
Medicina (Kaunas, Lithuania)|July 27, 2022
Future Perspectives in the Diagnosis and Treatment of Sepsis and Septic ShockIrene Karampela, Paraskevi C Fragkou
Metabolism Open|April 20, 2026
COVID-19 and metabolic health: Lessons from a global pandemicMaria Dalamaga, Irene Karampela, Junli Liu
Ophthalmology and Therapy|September 28, 2020
Does COVID-19 Involve the Retina?Michael Karampelas, Maria Dalamaga, Irene Karampela
Ophthalmology and Therapy|September 21, 2020
Does COVID-19 Involve the Retina?Michael Karampelas, Maria Dalamaga, Irene Karampela
Metabolism: Clinical and Experimental|June 5, 2020
Commentary: Phosphodiesterase 4 inhibitors as potential adjunct treatment targeting the cytokine storm in COVID-19Maria Dalamaga, Irene Karampela, Christos S Mantzoros
Pageof 10